Baylor College of Medicine awarded more than $1 million from NIH for Zika study Today The Vaccine Treatment and Evaluation Unit will lead a study of people infected with Zika virus to better understand the infection.
Angola Sickle Cell Initiative teaming with Bristol-Myers Squibb to provide children with medication for sickle cell disease Jun 24, 2016 The Angola Sickle Cell Initiative is teaming up with Bristol-Myers Squibb to provide access to medication for children with sickle cell disease in Angola.
Expert suggests new standards in child health as result of Zika Jun 20, 2016 The full pediatric neurological and psychiatric impact of Zika virus infection will take time to sort out and may not be fully realized for years, Dr. Peter Hotez explains in new JAMA Pediatrics editorial.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatment Jun 17, 2016 Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Baylor recognizes excellence among clinicians Jun 16, 2016 A select group of Baylor College of Medicine faculty members were recognized for excellence in patient care at the Master Clinician and Rising Star Clinician Awards ceremony.
New research finds controlled substance to be more harmful for infants when combined with cigarettes Jun 15, 2016 Researchers say that smoking both marijuana and tobacco cigarettes while pregnant may be worse for an unborn child than either cigarettes and marijuana alone.
First-of-its-kind children’s cancer center launches in Botswana capital Jun 13, 2016 The Botswana-Baylor Children’s Center of Excellence and the government of Botswana began development of the first children’s hematology and cancer center of excellence in Gaborone.
Zoghbi to receive the Shaw Prize in Life Science and Medicine for 2016 Jun 10, 2016 Dr. Huda Y. Zoghbi was awarded the 2016 Shaw Prize in Life Science and Medicine for her groundbreaking discovery of the genes and the encoded proteins associated with Rett syndrome.
Grant will allow for further study of pediatric blinding disease Jun 7, 2016 Dr. Nduka Enemchukwu has been awarded a $65,000grant from the Knights Templar Eye Foundation to support his research on blinding disease in children.
Evening With Genetics heads to McAllen, focuses on developmental disabilities Jun 2, 2016 Answers to questions about the cause of children’s disabilities, new testing, specific treatment and resources will be the focus of a public seminar in both English and Spanish.